Gymnemagenin-3-O-glucuronide mitigates lipopolysaccharide-induced acute lung inflammation/injury by regulating the NF-κB/MAPK signalling
Fields of Study & Subjects
NF-κB Signaling Pathways
Flavonoids in Medical Research
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Publication details
- Journal / source
- Naunyn-Schmiedeberg s Archives of Pharmacology
- Publisher
- Springer Science and Business Media LLC
- Volume
- 399
- Issue
- 9
- Pages
- 13759–13780
- Publication date
- 31 March 2026
- Language
- EN